BOTHELL, Wash., Feb. 20 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac monitoring and defibrillation products, announced today that it will release its fourth quarter 2006 financial results on Tuesday, February 27, 2007 after the market close. The Company has scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time to discuss the financial results for the fourth quarter and current business developments. The call will be hosted by John Hinson, chief executive officer, and Mike Matysik, chief financial officer.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO )
To access the conference call, please dial 800-218-8862. International participants can call 303-262-2130. The call will also be webcast live at www.cardiacscience.com. An audio replay of the call will be available for 7 days following the call at (800) 405-2236 for U.S. callers or (303) 590-3000 for those calling outside the U.S. The password required to access the replay is 11082862#. An archived webcast will also be available at www.cardiacscience.com for 90 days.
About Cardiac Science Corporation
Cardiac Science is truly at the heart of saving lives. The Company develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor -- defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services. The Company is the successor to various entities that have owned and operated cardiology-related businesses that sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered in Bothell, WA, and also has operations in Lake Forest, California; Deerfield, Wisconsin; Shanghai, China and Manchester, United Kingdom.
COMPANY CONTACT: Mike Matysik Cardiac Science Corporation Sr. Vice President and CFO (425) 402-2009 INVESTOR CONTACT: EVC Group, Inc. Douglas Sherk/Jenifer Kirtland (415) 896-6820 dsherk@evcgroup.com
Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comCardiac Science CorporationCONTACT: Mike Matysik of Cardiac Science Corporation, Sr. Vice Presidentand CFO, +1-425-402-2009; or investors, Douglas Sherk or Jenifer Kirtland,+1-415-896-6820, or dsherk@evcgroup.com, for Cardiac Science Corporation
Web site: http://www.cardiacscience.com/
